Invera Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Sell
13,617
-484
-3% -$40.3K 0.61% 44
2026
Q2
$950K Buy
14,101
+7,456
+112% +$497K 0.51% 53
2026
Q1
$417K Buy
6,645
+77
+1% +$5.36K 0.27% 76
2025
Q4
$436K Buy
+6,568
New +$425K 0.28% 72

Other funds holding DXCM

Invera Wealth Advisors's DXCM Position: Q3 2026 in Review

Invera Wealth Advisors reduced its DexCom (DXCM) stake by 3.4% in Q3 2026, selling an estimated $40.3K and leaving 13,617 shares worth $1.18M. The position accounts for 0.61% of the portfolio, ranked #44.

Invera Wealth Advisors first reported a position in DXCM in Q4 2025 and has held it in 4 quarters since. 863 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Invera Wealth Advisors held 13,617 shares of DexCom worth $1.18M as of Q3 2026.
  • Invera Wealth Advisors sold 484 DexCom shares in Q3 2026, an estimated $40.3K.
  • DexCom made up 0.61% of Invera Wealth Advisors's portfolio in Q3 2026, its #44 holding.
  • Invera Wealth Advisors first reported a position in DexCom in Q4 2025 and has held it in 4 quarters since.
  • 863 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Invera Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.